What is Hormona?
Launched in 2020 by founders Karolina Löfqvist and Jasmine Tagesson, Hormona operates at the intersection of biotechnology and consumer wellness. The company specializes in developing sophisticated digital tools and proprietary hardware designed to help women track, interpret, and manage complex hormonal fluctuations. By providing actionable data, Hormona is effectively positioning itself as a leader in the personalized healthtech space, moving beyond generic wellness tracking to provide clinical-grade insights that empower users to make informed decisions about their physiological well-being. The firm's market position is bolstered by its commitment to scientific rigor and user-centric design, addressing a historically underserved segment of the healthcare market.
How much funding has Hormona raised?
Hormona has raised a total of $6.8M across 2 funding rounds:
Seed
$6.7M
Grant
$136K
Seed (2025): $6.7M with participation from Nascent Investments, Voima Ventures, Supernode Global, Techstars, and DLF Venture
Grant (2025): $136K led by UK Research & Innovation
Key Investors in Hormona
Voima Ventures
Voima Ventures is a Nordic-based firm that funds scientific deep tech ventures, focusing on innovations that address global challenges through science-driven entrepreneurial expertise.
Supernode Global
Supernode Global is an early-stage venture capital fund that invests in consumer and B2B technologies, with a specific focus on wellbeing, productivity, and life optimization.
UK Research & Innovation
UK Research & Innovation is a public body that partners with research organizations and businesses to foster an environment where scientific innovation and technological advancement can flourish.
What's next for Hormona?
With this latest round of financing, Hormona is well-positioned to scale its operations and expand its product ecosystem. The strategic focus will likely shift toward enhancing the precision of its diagnostic hardware and deepening the integration of its digital platform with existing healthcare infrastructures. As the company transitions from its initial development phase into a broader commercialization strategy, the focus will remain on scaling its user base and establishing partnerships with clinical providers. By leveraging its recent capital, Hormona aims to solidify its status as a cornerstone of the digital health revolution, ensuring that hormonal health data becomes a standard component of proactive, preventative care for women globally.
See full Hormona company page
